Table 4.
Final results of different scenarios
| Cost (USD/Patient) | Effect (Per Patient) | Incremental results (Per Patient) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Governmental tariffs | Private tariffs | QALY | LYG | Inc-Cost/QALY | Inc-Cost/LYG | ||||||||
| Discount rate | Scenario | No-drug therapy | OTC statin | No-drug therapy | OTC statin | No-drug therapy | OTC statin | No-drug therapy | OTC statin | Governmental tariffs | Private tariffs | Governmental tariffs | Private tariffs |
| 0 % | Base-case | 214.70 | 652.05 | 445.21 | 830.02 | 26.37 | 26.77 | 33.82 | 34.29 | 1113.40 | 979.65 | 935.12 | 822.79 |
| ICS | 261.18 | 676.05 | 543.45 | 896.28 | 25.84 | 26.31 | 33.13 | 33.69 | 884.99 | 752.65 | 736.79 | 626.62 | |
| POM statin from 70 | 463.59 | 768.23 | 835.25 | 1107.22 | 26.50 | 26.80 | 33.98 | 34.34 | 1001.43 | 894.04 | 863.83 | 771.19 | |
| 3 % | Base-case | 110.71 | 384.95 | 231.85 | 477.97 | 16.56 | 16.74 | 20.71 | 20.91 | 1567.74 | 1407.00 | 1374.03 | 1233.16 |
| ICS | 128.68 | 394.62 | 270.32 | 504.34 | 16.37 | 16.57 | 20.46 | 20.70 | 1309.20 | 1152.07 | 1131.89 | 996.04 | |
| POM statin from 70 | 204.12 | 428.42 | 378.37 | 581.72 | 16.60 | 16.75 | 20.76 | 20.93 | 1526.75 | 1384.16 | 1369.28 | 1241.40 | |
| 7.2 % for costs & 3 % for effects | Base-case | 54.91 | 227.23 | 116.64 | 274.35 | 16.56 | 16.74 | 20.71 | 20.91 | 985.12 | 901.62 | 863.40 | 790.21 |
| ICS | 59.31 | 229.65 | 126.25 | 281.06 | 16.37 | 16.57 | 20.46 | 20.70 | 838.56 | 762.14 | 724.99 | 658.92 | |
| POM statin from 70 | 81.14 | 239.40 | 157.83 | 303.41 | 16.60 | 16.75 | 20.76 | 20.93 | 1077.21 | 990.87 | 966.11 | 888.68 | |